Literature DB >> 24869631

Diagnostic value of FDG-PET/(CT) in children with fever of unknown origin and unexplained fever during immune suppression.

Gijsbert J Blokhuis1, Chantal P Bleeker-Rovers, Marije G Diender, Wim J G Oyen, Jos M Th Draaisma, Lioe-Fee de Geus-Oei.   

Abstract

PURPOSE: Fever of unknown origin (FUO) and unexplained fever during immune suppression in children are challenging medical problems. The aim of this study is to investigate the diagnostic value of fluorine-18 fluorodeoxyglucose positron emission tomography (FDG-PET) and FDG-PET combined with computed tomography (FDG-PET/CT) in children with FUO and in children with unexplained fever during immune suppression.
METHODS: All FDG-PET/(CT) scans performed in the Radboud university medical center for the evaluation of FUO or unexplained fever during immune suppression in the last 10 years were reviewed. Results were compared with the final clinical diagnosis.
RESULTS: FDG-PET/(CT) scans were performed in 31 children with FUO. A final diagnosis was established in 16 cases (52 %). Of the total number of scans, 32 % were clinically helpful. The sensitivity and specificity of FDG-PET/CT in these patients was 80 % and 78 %, respectively. FDG-PET/(CT) scans were performed in 12 children with unexplained fever during immune suppression. A final diagnosis was established in nine patients (75 %). Of the total number of these scans, 58 % were clinically helpful. The sensitivity and specificity of FDG-PET/CT in children with unexplained fever during immune suppression was 78 % and 67 %, respectively.
CONCLUSIONS: FDG-PET/CT appears a valuable imaging technique in the evaluation of children with FUO and in the diagnostic process of children with unexplained fever during immune suppression. Prospective studies of FDG-PET/CT as part of a structured diagnostic protocol are warranted to assess the additional diagnostic value.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24869631     DOI: 10.1007/s00259-014-2801-z

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  43 in total

1.  CHILD CARE IN GENERAL PRACTICE. UNDIAGNOSED FEVER.

Authors:  E G BREWIS
Journal:  Br Med J       Date:  1965-01-09

2.  Fever of unexplained origin: report on 100 cases.

Authors:  R G PETERSDORF; P B BEESON
Journal:  Medicine (Baltimore)       Date:  1961-02       Impact factor: 1.889

3.  Role of integrated PET/CT with [¹⁸F]-FDG in the management of patients with fever of unknown origin: a single-centre experience.

Authors:  E Pelosi; A Skanjeti; D Penna; V Arena
Journal:  Radiol Med       Date:  2011-03-07       Impact factor: 3.469

4.  Place of (18)F-FDG-PET with computed tomography in the diagnostic algorithm of patients with fever of unknown origin.

Authors:  J Crouzet; V Boudousq; C Lechiche; J P Pouget; P O Kotzki; L Collombier; J P Lavigne; A Sotto
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-06-27       Impact factor: 3.267

5.  Value of FDG PET in patients with fever of unknown origin.

Authors:  J Lorenzen; R Buchert; K H Bohuslavizki
Journal:  Nucl Med Commun       Date:  2001-07       Impact factor: 1.690

6.  [18F] FDG PET/CT in patients with fever of unknown origin: a local experience.

Authors:  Pin Lin Kei; Tian Yue Kok; Ajit K Padhy; David C Ng; Anthony S Goh
Journal:  Nucl Med Commun       Date:  2010-09       Impact factor: 1.690

7.  Contribution of (18)fluoro-deoxyglucose positron emission tomography to the work-up of patients with fever of unknown origin.

Authors:  Ian Buysschaert; Steven Vanderschueren; Daniël Blockmans; Luc Mortelmans; Daniël Knockaert
Journal:  Eur J Intern Med       Date:  2004-06       Impact factor: 4.487

8.  Value of (18)F-FDG-PET/CT in patients with fever of unknown origin and unexplained prolonged inflammatory syndrome: a single centre analysis experience.

Authors:  L Federici; C Blondet; A Imperiale; J Sibilia; J-L Pasquali; F Pflumio; B Goichot; G Blaison; J-C Weber; D Christmann; A Constantinesco; E Andrès
Journal:  Int J Clin Pract       Date:  2008-05-08       Impact factor: 2.503

9.  Fever of unknown origin: a value of (18)F-FDG-PET/CT with integrated full diagnostic isotropic CT imaging.

Authors:  Jirí Ferda; Eva Ferdová; Jan Záhlava; Martin Matejovic; Boris Kreuzberg
Journal:  Eur J Radiol       Date:  2009-02-06       Impact factor: 3.528

10.  F-18-fluorodeoxyglucose positron emission tomography in diagnosis and follow-up of patients with different types of vasculitis.

Authors:  C P Bleeker-Rovers; S J H Bredie; J W M van der Meer; F H M Corstens; W J G Oyen
Journal:  Neth J Med       Date:  2003-10       Impact factor: 1.422

View more
  5 in total

Review 1.  18F-FDG-PET/CT Imaging to Diagnose Septic Emboli and Mycotic Aneurysms in Patients with Endocarditis and Cardiac Device Infections.

Authors:  Nidaa Mikail; Khadija Benali; Besma Mahida; Jonathan Vigne; Fabien Hyafil; François Rouzet; Dominique Le Guludec
Journal:  Curr Cardiol Rep       Date:  2018-03-06       Impact factor: 2.931

2.  PET Index of Bone Glucose Metabolism (PIBGM) Classification of PET/CT Data for Fever of Unknown Origin Diagnosis.

Authors:  Jian Yang; Xinxin Liu; Danni Ai; Jingfan Fan; Youjing Zheng; Fang Li; Li Huo; Yongtian Wang
Journal:  PLoS One       Date:  2015-06-15       Impact factor: 3.240

3.  Role of FDG-PET/CT in children with fever of unknown origin.

Authors:  Jordy P Pijl; Thomas C Kwee; G E Legger; Helja J H Peters; Wineke Armbrust; E H Schölvinck; Andor W J M Glaudemans
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-02-07       Impact factor: 9.236

4.  Fever of unknown origin (FUO) in children: a single-centre experience from Beijing, China.

Authors:  Bing Hu; Tian-Ming Chen; Shu-Ping Liu; Hui-Li Hu; Ling-Yun Guo; He-Ying Chen; Shao-Ying Li; Gang Liu
Journal:  BMJ Open       Date:  2022-03-16       Impact factor: 2.692

5.  Preoperative Prediction of Cervical Lymph Node Metastasis Using Primary Tumor SUVmax on 18F-FDG PET/CT in Patients with Papillary Thyroid Carcinoma.

Authors:  Ji-hoon Jung; Choon-Young Kim; Seung Hyun Son; Do-Hoon Kim; Shin Young Jeong; Sang-Woo Lee; Jaetae Lee; Byeong-Cheol Ahn
Journal:  PLoS One       Date:  2015-12-04       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.